FormWeb • Black Box Warning

Henry Ford Health

Approved Hospital Formulary

FormWeb QuickStart Questions or Suggestions? Pharmacy Intranet

Add Formweb to your mobile device

Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.

Henry Ford Health

Approved Hospital Formulary

FormWeb QuickStart Questions or Suggestions? Pharmacy Intranet

Black Box Warning

Please review each of these drugs carefully.

abacavir	Hypersensitivity
abacavir-lamivudine	Abacavir: hypersensitivity reactions; lactic acidosis, hepatomegaly
abacavir/dolutegravir/lamivudine	Hypersensitivity Reactions, Lactic Acidosis and Severe Hepatomegaly; Exacerbations of Hepatitis B
acetaminophen	Hepatotoxicity
acetaminophen-codeine	Addiction, Abuse, And Misuse; Life-Threatening Respiratory Depression; Risks From Concomitant Use With Benzodiazepines
acetaminophen-hydrocodone	Acetaminophen - Hepatotoxicity Hydrocodone - Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants
acetaminophen/butalbital/caffeine	Hepatotoxicity
acetylcysteine	Inhalation solution: not for injection
acitretin	Pregnancy/Teratogenecity
ado-trastuzumab emtansine	Hepatotoxicity, Cardiac Toxicity, Embryo-Fetal Toxicity
aldesleukin	Capillary Leak Syndrome
alemtuzumab	Hematological toxicity; opportunistic infections
ALPRAZolam	Risks From Concomitant Use in Opioids
alprostadil	Apnea
alvimopan	Short-term hospital use only
ambrisentan	Embryo-Fetal Toxicity
amikacin	Neurotoxicity; nephrotoxicity
aMILoride	Hyperkalemia
amiodarone	Oral: Pneumonitis; Proarrhythmic Effects
amitriptyline	Suicidal ideation in children, adolescents
amlodipine-benazepril	Benazepril: ACE inhibitor pregnancy risk
amphetamine-dextroamphetamine	Abuse/diversion potential; drug dependence
amphotericin B	Noninvasive fungal disease; avoid overdose
anti-thymocyte globulin (rabbit)	Used by Experienced Physicians in Immunosuppressive Therapy
apixaban	Discontinuation without anticoagulation
ARIPiprazole	Elderly patients with dementia related psychosis
arsenic trioxide	Cardiac toxicity
atenolol	Avoid abrupt withdrawal
atomoxetine	Suicidal Ideation
axicabtagene ciloleucel	Cytokine Release Syndrome and Neurologic Toxicities
azaTHIOprine	Risk of neoplasia, infections
baclofen	Intrathecal: Abrupt discontinuation
baricitinib	Serious Infections, Mortality, Malignancy, Major Adverse Cardiovascular Events (MACE), and Thrombosis
basiliximab	Prior to initiation of therapy
BCG	Risk of infection; biohazard handling precautions
belantamab mafodotin	Ocular Toxicity
belatacept	Post transplant lymphoproliferative disorder; serious infections
benazepril	ACE inhibitor pregnancy risk
bevacizumab	GI perforation; wound healing complications
bictegravir/emtricitabine/tenofovir	HepB coinfection
bleomycin	Pulmonary Fibrosis; Idiosyncratic Reactions
blinatumomab	Cytokine Release Syndrome and Neurological Toxities
bosentan	Hepatotoxicity; teratogenecity
brentuximab vedotin	Progressive Multifocal Leukoencephalopathy (PML)
brexucabtagene autoleucel	Cytokine Release Syndrome and Neurologic Toxicities
budesonide-formoterol	Asthma Related Death
bumetanide	Potent diuretic
bupivacaine	Intravascular injection risk; 0.75% strength caution
bupivacaine-epinephrine	Bupivacaine: Intravascular injection risk; 0.75% strength caution
bupivacaine-meloxicam	Risk of Serious Cardiovascular and Gastrointestinal Events
buprenorphine	Addiction, Abuse, And Misuse; Respiratory Depression; Neonatal Opioid Withdrawal Syndrome; Risks From Concomitant Use With Benzodiazepines
buPROPion	Suicidal Ideation
busulfan	Myelosuppression
butorphanol	Addiction, Abuse, And Misuse; Respiratory Depression; Neonatal Opioid Withdrawal Syndrome; and Risks From Concomitant Use With Benzodiazepines
cabazitaxel	Hemtalogical & Hypersensitivity Reactions
cabotegravir	Risk of Drug Resistance with Use of Cabotegravir for HIV-1 Pre-Exposure Prophylaxis (PrEP) in Undiagnosed HIV-1 Infection
capecitabine	Warfarin Interaction
captopril	Pregnancy risk
carBAMazepine	Hematological Risk; Serious Dermatologic Reactions
carbidopa-levodopa	Bolded (not boxed): Carbidopa dosing
CARBOplatin	Myelosuppression; Anaphylaxis risk
carfilzomib	Cardiac Toxicities; Tumor Lysis Syndrome; Pumonary Toxicity; Dyspnea; Hyprertension
carmustine	Bone Marrow Suppression; Pulmonary Toxicity
celecoxib	Cardiovascular, gastrointestinal risk
certolizumab	Serious infection risk
cetuximab	Infusion Reactions; Cardiopulmonary Arrest
chlordiazePOXIDE	Risks From Concomitant Use With Opioids
chlorproMAZINE	Mortality in elderly with dementia
cidofovir	Nephrotoxicity; Neutropenia
cilostazol	CHF patient contraindication
ciprofloxacin	Tendinitis; tendon rupture
CISplatin	Nephrotoxicity; Myelosuppression
citalopram	Suicidal Thoughts and Behaviors
cladribine	Bone Marrow Suppression; Neurotoxicity; Nephrotoxicity
clindamycin	Pseudomembranous colitis
cloBAZam	Risk From Concomitant Use with Opiods
clonazePAM	Risk From Concomitant Use With Opioids
cloNIDine	Epidural Clonidine
clopidogrel	Poor CYP2C19 metabolizers
clorazepate	Risks From Concomitant Use With Opioids
cloZAPine	Agranulocytosis, myocarditis, seizure risk
coagulation factor VIIa	Serious Thrombotic Adverse Events Associated with Recombinant Coagulation Factor VIIa Outside Label Indicatons
Coagulation Factor Xa (recombinant), inactivated-zhzo	Thromboembolic risks, ischemic risks, cardiac arrest, and sudden death
cobicistat/darunavir/emtricitabine/tenof	Exacerbations of Hepatitis B
cobicistat/elvitegravir/emtricitabine/tenofov	Lactic acidosis, severe hepatomegaly; hepB co-infection
cocaine topical	Topical: Not for injection or ophthalmic use.
codeine	Addiction, Abuse, And Misuse; Respiratory Depression; Neonatal Opioid Withdrawal Syndrome; and Risks From Concomitant Use With Benzodiazepines
codeine-guaifenesin	Codeine in children: death due to ultra-rapid metabolism
collagenase clostridium histolyticum	Corporal Rupture or Other Serious Penile Injury in the Treatment of Peyronie's Disease
conjugated estrogens	Endometrial cancer; cardiovascular; dementia risk
conjugated estrogens topical	Endometrial cancer; cardiovascular; dementia risk
cycloSPORINE	Infection, neoplasm, nephrotoxicity risk
cytarabine	Prior to initiation of therapy
cytarabine liposomal-daunorubicin liposomal	Do not interchange with other Daunorubicin and/or Cytarabine containing products
dabigatran	Discontinuation without anticoagulation
dacarbazine	Hemopoietic depression; hepatic necrosis risk
DACTINomycin	Handling precautions; extravasation risk
danazol	Pregnancy contraindication; stroke risk; hepatic risk with long term use; benign intracranial hypertension
dantrolene	Hepatotoxicity
darbepoetin alfa	Mortality, serious CV events, tumor progression or recurrence
DAUNOrubicin	Cardiac, myelosuppression, extravasation risk
daxibotulinumtoxinA	Distant spread of toxin effect
denosumab	Prolia - Severe Hypocalcemia in Patients with Advanced Kidney Disease
desvenlafaxine	Suicidal ideation
dexmethylphenidate	Caution in drug dependent patients; supervised withdrawal
diatrizoate	Not for intrathecal use
diazePAM	Risks From Concomitant Use With Opioids
diclofenac topical	Cardiovascular, gastrointestinal risk
dihydroergotamine	Drug interaction risk
disopyramide	Mortality Risk
disulfiram	Administer with patient consent
divalproex sodium	Hepatotoxicity; mitochondrial disease; fetal risk
DOCEtaxel	Hepatic dysfunction, hypersensitivity risk
dofetilide	Initiation or re-initiation monitoring
DOPamine	Peripheral ischemia risk
doxepin	Suicidal Ideation
DOXOrubicin	Cardiac, hepatic, myelosuppression, extravasation risk
DOXOrubicin liposomal	Cardiac, acute infusion reaction, myelosuppresssion risk
dronedarone	Contraindication in certain CHF conditions
droperidol	QT Prolongation
DULoxetine	Suicidal Ideation
eculizumab	Serious Meningococcal Infections
edoxaban	Reduced efficacy; risk of ischemic events; spinal/epidural hematoma
efavirenz/emtricitabine/tenofovir	Lactic Acidosis; Severe Hepatomegaly with Steatosis and Post Treatment Exacerbation of Hepatitis B
emtricitabine	Lactic Acidosis, Severe Hepatomegaly
emtricitabine-tenofovir	Lactic acidosis; severe hepatomegaly; hepB co-infection
emtricitabine/rilpivirine/tenofovir	Lactic acidosis, severe hepatomegaly; hepB co-infection
enalapril	Pregnancy risk
enoxaparin	Spinal/epidural hematoma risk
entecavir	Lactic acidosis, severe hepatomegaly; hepB co-infection
epcoritamab	Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syncrome
epiRUBicin	Cardiac Toxicity, Secondary Malignancies, Extravasation & Tissue Necrosis, and Severe Myelosuppression
epoetin alfa	Risk of mortality, tumor progression, cardiac events
escitalopram	Suicidal ideation
esketamine	Sedation; Dissociation; Abuse and Misuse; and Suicidal Thoughts and Behaviors
esterified estrogens-methyltestosterone	Endometrial cancer; cardiovascular; dementia risk
estradiol	Transdermal: endometrial cancer; cardiovascular; dementia risk Vaginal cream/tab: endometrial cancer; cardiovascular; dementia risk
estradiol topical	Endometrial cancer; cardiovascular; dementia risk
etanercept	Infection risk; tuberculosis
ethacrynic acid	Potent Diuretic
ethiodized oil	For Intralymphatic, Intrauterine and Selective Hepatic Intra-Arterial Use Only
etoposide	Myelosuppression risk
everolimus	Malignancies and Serious Infections, Nephrotoxicity, Kidney Graft Thrombosis, Mortality in Heart Transplantation
fam-trastuzumab deruxtecan-nxki	Interstitial Lung Disease and Embryo-Fetal Toxicity
fat emulsion, intravenous	Cautious use in infants Death in preterm infants
felbamate	Aplastic anemia; liver failure risk
fentaNYL	Buccal Tablet: Serious adverse events, deaths; abuse potential Nasal Spray: Schedule II Controlled Substance: Abuse potential Sublingual Spray: Risk of respiratory depression, medication errors, abuse potential Transdermal: High concentration of Schedule II opioid agonist
ferrous gluconate	Iron Overdose Risk
ferrous sulfate	Iron Overdose Risk
ferumoxytol	Risk For Serious Hypersensitivity/Anaphylaxis Reactions
flecainide	Cardiovascular risk
floxuridine	Hematologic risk
flucytosine	Hepatic, hematologic risks; caution in renal impairment
fludarabine	Neurotoxicity, hemolytic anemia risk
flumazenil	Seizure Risk
fluorouracil	Hematologic risk
FLUoxetine	Suicidal Ideation
fluPHENAZine	Mortality in elderly with dementia
flutamide	Hepatotoxicity
fondaparinux	Spinal/epidural hematoma risk
foscarnet	Nephrotoxicity; seizure risk
furosemide	Potent Diuretic
gadobenate dimeglumine	Nephrogenic Systemic Fibrosis
gadobutrol	Nephrogenic Systemic Fibrosis
gadoterate meglumine	Nephrogenic Systemic Fibrosis
gadoxetate	Nephrogenic Systemic Fibrosis
ganciclovir	Hematological toxicity; IV and oral different indications
gemtuzumab ozogamicin	Hematological, Hepatotoxicity, Anaphlyaxis; use as single agent
gentamicin	Ototoxicity; Nephrotoxocity
haloperidol	Mortality in elderly with dementia
hemin	Use only after alternative therapy failure
heparin	Spinal/Epidural Hematomas
hetastarch	Renal injury risk
hyaluronidase-rituximab	Fatal Infusion Reaction; Mucocutaneous Reactions; Progressive Multifocal Leukoencephalopathy; Hep b Reactivation
hyaluronidase/pertuzumab/trastuzumab	Cardiomyopathy, Embryo-Fetal Toxicity, and Pulmonary Toxicity
hydrochlorothiazide-lisinopril	Lisinopril: ACE inhibitor pregnancy risk
hydrochlorothiazide-spironolactone	Possible tumorigen
hydrochlorothiazide-triamterene	Hyperkalemia
HYDROmorphone	Injection: Respiratory depression risk; abuse potential Injection, High Potency: Opioid-tolerant patients only; Respiratory depression risk; abuse potential Oral, extended release: Opioid-tolerant patients only; overdose risk; abuse potential Oral, liquid & tablets: Abuse potential; respiratory depression; neonatal withdrawal; alcohol interaction
hydroxychloroquine	Prior to initiation of therapy
hydroxyurea	Prior to initiation of therapy
ibuprofen	Cardiovascular; gastrointestinal risk
ibutilide	Potentially Fatal Arrhythmias
IDArubicin	Cardiotoxicity; myelosuppression; renal/hepatic impairment; avoid extravasation
idecabtagene vicleucel	Cytokine Release Syndrome, Neurologic Toxicities, HLM/MAS and Prolonged Cytopenia
ifosfamide	Urotoxicity; myelosuppressionm CNS toxicity
imipramine	Suicidal ideation
immune globulin intramuscular	Renal dysfunction, acute renal failure
immune globulin intravenous	Renal dysfunction, acute renal failure
immune globulin intravenous and subcutaneous	Renal dysfunction, acute renal failure
incobotulinum toxin A	Distant spread of toxin effect
indomethacin	Cardiovascular; gastrointestinal risk
inFLIXimab	Serious infection risk; hepatosplenic t-cell lymphomas; malignancy
interferon alfa-2b	Risk of Serious Disorders
iopamidol	Not for intrathecal use
ioversol	Not for Intrathecal
ipilimumab	Immune-Mediated Adverse Reactions
irinotecan	Severe diarrhea
irinotecan liposomal	Severe diarrhea Severe neutropenia
iron dextran	Injection: Anaphylactic reaction risk
iron polysaccharide	Iron overdose risk
isoniazid	Hepatitis
itraconazole	Congestive heart failure, drug interactions
ixabepilone	Toxicity in hepatic impariment
ketamine	Emergence reactions; psychological manifestations
ketoconazole	Oral: hepatoxicity, drug interactions
ketorolac	Duration of therapy; max dose; GI, cardiovascular, bleeding, renal risk Nasal Spray - Risk of Serious Cardiovascular and Gastrointestinal Events
lamiVUDine	Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
lamivudine-zidovudine	Lamivudine: Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation Zidovudine: Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
lamoTRIgine	Serious dermatological reactions
levoFLOXacin	Tendinitis, tendon rupture
levonorgestrel-releasing intrauterine system	Warning
levothyroxine	Treatment of obesity or weight loss
lidocaine topical	Lidocaine, viscous: Do NOT use for teething pain
liothyronine	Treatment of obesity or weight loss
lisdexamfetamine	High abuse/diversion potential; drug dependence
lisinopril	ACE inhibitor pregnancy risk
lisocabtagene maraleucel	Cytokine Release Syndrome and Neurologic Toxicities
lithium	Monitoring recommendations
lomustine	Bone marrow suppression; qualified physician
lopinavir-ritonavir	Ritonavir: Drug interactions
LORazepam	Risks From Concomitant Use With Opioids
losartan	Pregnancy risk
lurasidone	Mortality in elderly patients with dementia related psychosis
LVP solution	Extraneal: Unrecognized Hypoglycemia Resulting From Drug-Device Interaction
lymphocyte immune globulin, anti-thy (equine)	Prior to initiation of therapy
macitentan	Embryo-Fetal Toxicity
mannitol	Severe bronchospasm risk
maraviroc	Hepatotoxicity
medroxyPROGESTERone	Oral: Cardiovascular and other risks Injection: Loss of Bone Mineral Density
meloxicam	Cardiovascular; gastrointestinal risk
melphalan	Bone marrow suppression; hypersensitivity reactions; pregnancy risk
meperidine	Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome
mercaptopurine	Bolded (not boxed): initiation of therapy
metFORMIN	Lactic Acidosis
methacholine	Diagnostic use only
methadone	Risk during initiation of or conversion to methadone
methohexital	Continuous monitoring of respiratory and cardiac function
methotrexate	Bone marrow, liver, lung and kidney toxicity risk
methoxsalen	Oral: Methoxsalen with UV radiation should be used only by physicians who have special competence in the diagnosis and treatment of psoriasis and who have special training and experience in photochemotherapy. Injection: Used Only By Specialized Physicians
methyldopa	Fixed combination for initial hypertension management
methylene blue	Serotonin Syndrome with Concomitant Use of Serotonergic Drugs
methylphenidate	Tolerance and dependence
metoclopramide	Tardive Dyskinesia
metOLazone	Bolded (not boxed): do not interchange
metroNIDAZOLE	Carcinogenicity
mexiletine	Mortality; Acute Liver Injury
midazolam	Individualize dose
midodrine	Supine blood pressure > 180 mmHg
miFEPRIStone	Serious infections or bleeding
minoxidil	Antihypertensive risk
mirtazapine	Suicidal ideation
mirvetuximab soravtansine	Ocular Toxicity
miSOPROStol	Pregnancy risk
mitoMYcin	Bone marrow suppression; hemolytic uremic syndrome
mitotane	Temporarily stop therapy after shock or severe trauma because drug's prime action is adrenal suppression.
mitoXANTRONE	Cardiotoxicity; baseline neutrophil count; extravasation risk
montelukast	Serious Neuropsychiatric Events
morphine	Injection PreserveFree: 24-hour observation following epidural/intrathecal administration Controlled/Extended Release: Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome
moxifloxacin	Tendinitis, tendon rupture
mycophenolate mofetil	Prior to initiation of therapy
mycophenolic acid	Embryofetal Toxicity, Malignancies, and Serious Infections
nadolol	Avoid abrupt withdrawal
nalbuphine	Life-Threatening Respiratory Depression
naproxen	Cardiovascular; gastrointestinal risk
natalizumab	Progressive multifocal leukoencephalopathy (PML)
neomycin	Neurotoxicity, nephrotoxicity, ototoxicity; general toxicity
nevirapine	Hepatotoxicity; dermal reactions; patient monitoring
niMODipine	Serious harm with IV administration of oral product
norepinephrine	Extravasation risk
nortriptyline	Suicidal ideation
obinutuzumab	Hepatitis B Reactivation and PML
OLANZapine	Mortality in elderly with dementia related psychosis
omalizumab	Anaphylaxis
onabotulinumtoxinA	Distant spread of toxin effect
oxaliplatin	Anaphylactic-like reactions
oxazepam	Risks From Concomitant Use With Opioids
oxyCODONE	Oral solution: Risk of errors Controlled release: Abuse potential
oxytocin	Elective induction of labor
PACLitaxel	Prior to initiation of therapy
PACLitaxel protein-bound	Prior to initiation of therapy
paliperidone	Mortality in elderly patients with dementia related psychosis
panitumumab	Dermatologic toxicity; infusion reactions
PARoxetine	Suicidal ideation
pegcetacoplan	Serious Infections Caused By Encapsulated Bacteria
peginterferon alfa-2a	Neuropsychiatric, autoimmune, ischemic and infectious disorders
pegloticase	Anaphylaxis and Infusion Reactions, G6PD Deficiency associated Hemolysis and Methemoglobinemia
pentostatin	Prior to initiation of therapy
perampanel	Serious psychiatric and behavioral reactions
perflutren	Serious cardiopulmonary reactions
perphenazine	Elderly patients with dementia related psychosis
pertuzumab	Cardiomyopathy and Embryo-Fetal Toxicity
phenelzine	Suicidal ideation
phenylephrine	Prior to initiation of therapy
phenytoin	Cardiovascular risk with rapid infusion
phytonadione	Severe reactions with IM and IV use
pimecrolimus topical	Long-term safety
pioglitazone	Congestive heart failure
plasma protein fraction	Liver transplant, severe liver disease and coagulopathies
polymyxin B sulfate	Parenteral use: nephrotoxicity, neurotoxicity, pregnancy risk
prabotulinumtoxinA	Distant Spread of Toxin Effect
prasugrel	Bleeding risk
primaquine	Prior to initiation of therapy
procainamide	Positive titers with chronic administration
prochlorperazine	Elderly patients with dementia related psychosis
progesterone	Cardiovascular disorders; breast cancer; probable dementia
promethazine	Patients < 2 years; severe tissue injury
propafenone	Mortality (CAST trial results)
propranolol	Avoid abrupt withdrawal
propylthiouracil	Severe liver injury; acute liver failure
protamine	Hypotension, pulmonary hypertension; risk factors described
prothrombin complex	Arterial and venous thromboembolic complications
QUEtiapine	Elderly patients with dementia related psychosis
quiNIDine	Active antiarrhythmic therapy may increase mortality
ramipril	Olmesartan: ACE inhibitor pregnancy risk
rasburicase	Anaphylaxis; hemolysis; methemoglobinemia; uric acid measure interference
ravulizumab	Serious Meningococcal Infections
remdesivir	Black Box Warning is for Use of Remdesivir to Treat COVID-19
remifentanil	Addiction, Abuse, and Misuse
RHo (D) immune globulin	Intravenous - Intravascular Hemolysis
ribavirin	Oral: Monotherapy; hemolytic anemia; teratogenicity Inhalation: Respiratory function deterioration
rimabotulinumtoxinB	Distant Spread of Toxin Effect
riociguat	Embryo-Fetal Toxicity
risperiDONE	Elderly patients with dementia related psychosis
ritonavir	Drug interaction risk
riTUXimab	Fatal infusion reaction; mucocutaneous reactions; progressive multifocal leukoencephalopathy; hep b reactivation
rivaroxaban	Premature discontinuation; spinal/epidural hematomas
rocuronium	Prior to initiation of therapy
romosozumab	Potential Risk of Myocardial Infarction, Stroke and Cardiovascular Death
sacituzumab govitecan	Neutropenia and Diarrhea
sacubitril-valsartan	Valsartan: ACE inhibitor pregnancy risk
salmeterol	Asthma Related Deaths
selegiline	Suicidal ideation
sertraline	Suicidal ideation
sirolimus	Immunosuppression; liver or lung transplant patients
sodium nitrite-sodium thiosulfate	Life Threatening Hypotension and Methemoglobin Formation
sodium nitroprusside	Cyanide toxicity; hypotension risk; dilute
sodium phosphate	Phosphate nephropathy
sotalol	Therapy initiation; renal impairment caution; product selection
streptomycin	Neurotoxicity; nephrotoxicity
streptozocin	Nephrotoxicity; experienced physician; mutagen
succinylcholine	Hyperkalemic rhabdomyolysis in infants or children
SUFentanil	Addition, Abuse, and Misuse
sulfur hexafluoride	Serious cardiopulmonary reactions
sulindac	Cardiovascular; gastrointestinal risk
tacrolimus	Lymphoma risk; infection related to immunosuppression
talquetamab	Cytokine Release Syndrome and Neurologic Toxicity
tamoxifen	Women at high risk for breast cancer; women with DCIS
teclistamab	Cytokine Release Syndrome and Neurologic Toxicity
temazepam	Risks From Concomitant Use With Opioids
tenofovir	Lactic acidosis, severe hepatomegaly; hepB co-infection
terbutaline	Preterm labor (injectable and oral)
terlipressin	Serious or Fatal Respiratory Failure
testosterone	Secondary exposure to testosterone Testosterone undecanoate, injection: POME reactions and anaphylaxis
thiotepa	Severe myelosuppression, carcinogenicity
thiothixene	Elderly patients with dementia related psychosis
thrombin topical	Bleeding, thrombosis risk
thyroid desiccated	Treatment of obesity or weight loss
ticagrelor	Bleeding Risk
tinidazole	Carcinogenicity
tisagenlecleucel	Cytokine Release Syndrome and Neurological Toxicities
tiZANidine	Bolded (not boxed): bioequivalence between products
tobramycin	Ototoxicity, nephrotoxicity risk with IV use
tocilizumab	Serious infections risk
tolcapone	Hepatotoxicity
tolvaptan	Initiation or re-initiation monitoring
topotecan	Bone marrow suppression
traMADol	Addiction, Abuse, and Misuse; Life-Threatening Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome; and Hepatotoxicity
trastuzumab	Cardiomyopathy; infusion reactions, pulmonary toxicity; teratogenicity
traZODone	Suicidal ideation
tretinoin	Acute promyelocytic leukemia; experienced physician
valbenazine	Depression and Suicidal Ideation
valGANciclovir	Hematologic Toxicity; Impairment of Fertility; Fetal Toxocity; Mutagenesis & Carcinogenesis
valproic acid	Risk to children exposed in utero
valsartan	ACE inhibitor pregnancy risk
vancomycin	Risk of Embryo-Fetal Toxicity Due to Excipient Containing Products
venetoclax	Tumor Lysis Syndrome
venlafaxine	Suicidal ideation
vinBLAStine	IV use only; granulocytopenia; avoid extravasation
vinCRIStine	IV use only; dose liposomal product differently
vinorelbine	IV use only; granulocytopenia; avoid extravasation
warfarin	Serious bleeding risk
ziconotide	Severe psychiatric symptoms, neurological impairment
zidovudine	Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
ziprasidone	Mortality in elderly with dementia related psychosis
zolpidem	Complex Sleep Behaviors

This site is intended for the staff of Henry Ford Health.
While others may view accessible pages, Henry Ford Health makes no warranty, express or implied,
as to the use of this information outside of Henry Ford Health.